0 XP   0   0   0

IVERIC bio Inc










Financial Health of IVERIC bio Inc




Comparing to competitors in the Biotechnology industry




  Industry Rankings  


IVERIC bio Inc
Buy, Hold or Sell?

Should you buy, hold or sell IVERIC bio Inc?

I guess you are interested in IVERIC bio Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse IVERIC bio Inc

Let's start. I'm going to help you getting a better view of IVERIC bio Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is IVERIC bio Inc even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how IVERIC bio Inc is doing in the market. If the company is worth buying. The latest step is to find out how other investors value IVERIC bio Inc. The closing price on 2022-12-02 was $23.06 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
IVERIC bio Inc Daily Candlestick Chart

Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of IVERIC bio Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit IVERIC bio Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare IVERIC bio Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of IVERIC bio Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-384.4%+384.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--223.6%+223.6%
TTM--281.7%+281.7%
YOY--344.8%+344.8%
5Y--450.1%+450.1%
10Y-384.4%-541.0%+156.6%
1.1.2. Return on Assets

Shows how efficient IVERIC bio Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare IVERIC bio Inc to the Biotechnology industry mean.
  • -12.8% Return on Assets means that IVERIC bio Inc generated $-0.13 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of IVERIC bio Inc:

  • The MRQ is -12.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -11.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-12.8%TTM-11.6%-1.2%
TTM-11.6%YOY-13.5%+1.9%
TTM-11.6%5Y-7.0%-4.6%
5Y-7.0%10Y-9.3%+2.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-12.8%-9.9%-2.9%
TTM-11.6%-8.9%-2.7%
YOY-13.5%-9.3%-4.2%
5Y-7.0%-11.7%+4.7%
10Y-9.3%-12.7%+3.4%
1.1.3. Return on Equity

Shows how efficient IVERIC bio Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare IVERIC bio Inc to the Biotechnology industry mean.
  • -16.3% Return on Equity means IVERIC bio Inc generated $-0.16 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of IVERIC bio Inc:

  • The MRQ is -16.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -13.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-16.3%TTM-13.2%-3.2%
TTM-13.2%YOY-15.4%+2.3%
TTM-13.2%5Y-27.0%+13.8%
5Y-27.0%10Y-16.9%-10.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-16.3%-12.0%-4.3%
TTM-13.2%-11.5%-1.7%
YOY-15.4%-10.8%-4.6%
5Y-27.0%-14.2%-12.8%
10Y-16.9%-15.2%-1.7%

1.2. Operating Efficiency of IVERIC bio Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient IVERIC bio Inc is operating .

  • Measures how much profit IVERIC bio Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare IVERIC bio Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of IVERIC bio Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-393.3%+393.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--207.3%+207.3%
TTM--271.0%+271.0%
YOY--325.9%+325.9%
5Y--454.0%+454.0%
10Y-393.3%-537.1%+143.8%
1.2.2. Operating Ratio

Measures how efficient IVERIC bio Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of IVERIC bio Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y4.286-4.286
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.871-2.871
TTM-3.504-3.504
YOY-3.604-3.604
5Y-5.132-5.132
10Y4.2866.371-2.085

1.3. Liquidity of IVERIC bio Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if IVERIC bio Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 13.40 means the company has $13.40 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of IVERIC bio Inc:

  • The MRQ is 13.400. The company is very able to pay all its short-term debts. +2
  • The TTM is 14.357. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ13.400TTM14.357-0.957
TTM14.357YOY9.123+5.234
TTM14.3575Y12.528+1.829
5Y12.52810Y13.640-1.113
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ13.4005.117+8.283
TTM14.3575.755+8.602
YOY9.1235.854+3.269
5Y12.5286.511+6.017
10Y13.6406.222+7.418
1.3.2. Quick Ratio

Measures if IVERIC bio Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare IVERIC bio Inc to the Biotechnology industry mean.
  • A Quick Ratio of 19.85 means the company can pay off $19.85 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of IVERIC bio Inc:

  • The MRQ is 19.846. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 20.484. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ19.846TTM20.484-0.638
TTM20.484YOY14.077+6.407
TTM20.4845Y14.909+5.575
5Y14.90910Y17.887-2.978
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ19.8464.284+15.562
TTM20.4844.664+15.820
YOY14.0774.787+9.290
5Y14.9095.218+9.691
10Y17.8875.182+12.705

1.4. Solvency of IVERIC bio Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of IVERIC bio Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare IVERIC bio Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.22 means that IVERIC bio Inc assets are financed with 21.8% credit (debt) and the remaining percentage (100% - 21.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of IVERIC bio Inc:

  • The MRQ is 0.218. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.108. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.218TTM0.108+0.110
TTM0.108YOY0.117-0.009
TTM0.1085Y0.253-0.145
5Y0.25310Y0.645-0.392
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2180.278-0.060
TTM0.1080.277-0.169
YOY0.1170.306-0.189
5Y0.2530.367-0.114
10Y0.6450.403+0.242
1.4.2. Debt to Equity Ratio

Measures if IVERIC bio Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare IVERIC bio Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 27.8% means that company has $0.28 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of IVERIC bio Inc:

  • The MRQ is 0.278. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.127. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.278TTM0.127+0.151
TTM0.127YOY0.133-0.006
TTM0.1275Y2.141-2.013
5Y2.14110Y2.684-0.543
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2780.315-0.037
TTM0.1270.317-0.190
YOY0.1330.319-0.186
5Y2.1410.403+1.738
10Y2.6840.462+2.222

2. Market Valuation of IVERIC bio Inc

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings IVERIC bio Inc generates.

  • Above 15 is considered overpriced but always compare IVERIC bio Inc to the Biotechnology industry mean.
  • A PE ratio of -51.14 means the investor is paying $-51.14 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of IVERIC bio Inc:

  • The EOD is -65.733. Company is losing money. -2
  • The MRQ is -51.139. Company is losing money. -2
  • The TTM is -48.662. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-65.733MRQ-51.139-14.595
MRQ-51.139TTM-48.662-2.476
TTM-48.662YOY-41.443-7.219
TTM-48.6625Y-32.431-16.232
5Y-32.43110Y-29.712-2.718
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-65.733-8.986-56.747
MRQ-51.139-9.792-41.347
TTM-48.662-16.243-32.419
YOY-41.443-20.876-20.567
5Y-32.431-16.665-15.766
10Y-29.712-14.732-14.980
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of IVERIC bio Inc.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of IVERIC bio Inc:

  • The MRQ is -313.335. Very Bad. -2
  • The TTM is 338.826. Seems overpriced? -1
Trends
Current periodCompared to+/- 
MRQ-313.335TTM338.826-652.161
TTM338.826YOY-11,479.979+11,818.805
TTM338.8265Y-3,193.473+3,532.299
5Y-3,193.47310Y-1,068.983-2,124.490
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-313.335-0.032-313.303
TTM338.8260.004+338.822
YOY-11,479.9790.016-11,479.995
5Y-3,193.4730.006-3,193.479
10Y-1,068.9830.003-1,068.986

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of IVERIC bio Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 8.35 means the investor is paying $8.35 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of IVERIC bio Inc:

  • The EOD is 10.727. Seems overpriced? -1
  • The MRQ is 8.345. Seems overpriced? -1
  • The TTM is 6.002. Seems overpriced? -1
Trends
Current periodCompared to+/- 
EOD10.727MRQ8.345+2.382
MRQ8.345TTM6.002+2.343
TTM6.002YOY5.733+0.269
TTM6.0025Y8.210-2.208
5Y8.21010Y26.296-18.086
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD10.7271.835+8.892
MRQ8.3452.006+6.339
TTM6.0022.774+3.228
YOY5.7333.453+2.280
5Y8.2102.713+5.497
10Y26.2962.402+23.894
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of IVERIC bio Inc.

3.1. Institutions holding IVERIC bio Inc

Institutions are holding 106.546% of the shares of IVERIC bio Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2022-06-30State Street Corporation7.39650.0058733590284374748.2822
2022-06-30HHG PLC6.9020.054181497196704654463.969
2022-06-30venBio Select Advisor LLC6.02991.35357120000-130000-1.7931
2022-06-30Vanguard Group Inc5.06610.001659819162031873.5161
2022-06-30Vivo Capital, LLC4.43665.06045238634-1193306-18.5528
2022-06-30Deerfield Management Co4.41571.034652140003220046.5823
2022-06-30Yiheng Capital LLC4.28412.7827505858500
2022-06-30Deep Track Capital, LP3.8112.8457450000000
2022-06-30T. Rowe Price Associates, Inc.2.87110.00413390140-1220136-26.4656
2022-06-30TCG Crossover Management, LLC2.468111.9088291425039733015.7864
2022-06-30Capital Research & Mgmt Co - Division 32.27160.007268223026822300
2022-06-30Deutsche Bank AG2.05060.013242132223175982234.3893
2022-06-30COMMODORE CAPITAL LP2.0414.901824099611950008.8038
2022-06-30Perceptive Advisors LLC1.76830.62912087956-3137459-60.0423
2022-06-30Geode Capital Management, LLC1.6820.00281986035-4572-0.2297
2022-06-30Polar Capital Holdings PLC1.58250.1056186862800
2022-06-30Two Sigma Advisers, LLC1.37950.0445162890035370027.7368
2022-06-30Millennium Management LLC1.36310.0096160949534653627.4384
2022-06-30Redmile Group, LLC1.28640.5581518900331002.2278
2022-06-30Candriam Luxembourg S.C.A.1.2420.1162146657148562049.505
Total 64.348131.438175980832+11199233+14.7%

3.2. Funds holding IVERIC bio Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2022-10-31SPDR® S&P Biotech ETF3.67971.41594344873-12160-0.2791
2022-10-31Vanguard Total Stock Mkt Idx Inv2.99420.00733535483143250.4068
2022-09-30Vanguard Instl Ttl Stck Mkt Idx Tr2.98210.0063521158708132.0523
2022-10-31iShares Russell 2000 ETF2.22920.1182263216685880.3273
2022-09-30American Funds SMALLCAP World A1.83280.06992164099-518131-19.3172
2022-09-30Polar Capital Healthcare Opports Inc1.53162.0182180851500
2022-09-30Janus Henderson Global Life Sciences D1.4010.74921654329-830538-33.4238
2022-09-30Janus Henderson Global Life Sciences1.4010.74471654329-830538-33.4238
2022-09-30T. Rowe Price Health Sciences1.35990.20851605737350702.2328
2022-09-30Janus Henderson Glb Life Scn I2 USD1.29310.78441526809-428371-21.9095
2022-10-31Vanguard Extended Market Index Investor1.27760.0431150851696160.6415
2022-09-30Janus Global Life Science A USD1.23820.74641462008-789092-35.0536
2022-09-30AB Small Cap Growth A1.12570.6267132917013291700
2022-09-30Franklin Biotechnology Discv A(acc)USD0.9731.2245114884115140015.1788
2022-09-30T. Rowe Price New Horizons0.95970.09681133174282832.5598
2022-07-31Biotech Growth Ord0.82622.261797560020520026.6355
2022-10-31iShares Russell 2000 Growth ETF0.79720.2335941316-4416-0.4669
2022-08-31Fidelity® Small Cap Index0.75640.0469893198190072.1742
2022-10-31iShares Biotechnology ETF0.69650.243982242239360.4809
2022-09-30SEB Läkemedelsfond0.55860.994465955521844249.5206
Total 29.913712.640235321298-1319396-3.7%

3.3. Insider Transactions

Insiders are holding 0.567% of the shares of IVERIC bio Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2022-11-02Glenn SblendorioSELL5000023.01179689
2022-11-01Keith WestbySELL7291623.9269128
2022-08-03Christopher Paul SimmsSELL1227211.2528547
2022-07-05Anthony S GibneySELL77919.4110959
2022-06-13Calvin W RobertsBUY250009.6232500
2022-04-18Keith WestbySELL1000016.6399128
2022-04-05David Francis CarrollSELL468419.0140166
2022-04-05Keith WestbySELL929819.02109128
2022-04-04Glenn SblendorioSELL5000018.76229689
2022-04-01Glenn SblendorioSELL4075617.5
2022-04-01David Francis CarrollSELL21441740166
2022-03-30Glenn SblendorioSELL121317
2022-03-25David Francis CarrollSELL1677217.02
2022-03-25Glenn SblendorioSELL1877517.06
2022-03-18David Francis CarrollSELL1156117
2022-03-18Glenn SblendorioSELL347917
2022-02-07Keith WestbySELL1000015
2022-01-03David Francis CarrollSELL1581916.39
2022-01-03Keith WestbySELL1227816.39
2021-12-27Glenn SblendorioSELL522916.64

4. Summary

4.1. Key Performance Indicators

The key performance indicators of IVERIC bio Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.2770.068-505%0.025-1223%0.089-410%0.054-615%
Book Value Growth---0.1290.006-2283%-0.020-84%-0.111-14%-0.040-69%
Book Value Per Share--2.1502.581-17%1.501+43%1.310+64%0.894+140%
Book Value Per Share Growth---0.1290.006-2283%-0.020-84%-0.111-14%-0.040-69%
Current Ratio--13.40014.357-7%9.123+47%12.528+7%13.640-2%
Debt To Asset Ratio--0.2180.108+102%0.117+86%0.253-14%0.645-66%
Debt To Equity Ratio--0.2780.127+119%0.133+109%2.141-87%2.684-90%
Dividend Per Share----0%-0%-0%-0%
Eps---0.351-0.330-6%-0.221-37%-0.137-61%-0.141-60%
Eps Growth--0.163-0.109+167%0.017+881%-1.518+1030%-0.449+375%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin----0%-0%-0%-3.8440%
Operating Margin----0%-0%-0%-3.9330%
Operating Ratio----0%-0%-0%4.286-100%
Pb Ratio10.727+22%8.3456.002+39%5.733+46%8.210+2%26.296-68%
Pe Ratio-65.733-29%-51.139-48.662-5%-41.443-19%-32.431-37%-29.712-42%
Peg Ratio---313.335338.826-192%-11479.979+3564%-3193.473+919%-1068.983+241%
Price Per Share23.060+22%17.94015.278+17%8.910+101%6.775+165%18.257-2%
Price To Total Gains Ratio-83.300-29%-64.805-38.213-41%-17.967-72%-21.852-66%-40.370-38%
Profit Growth--16.321-10.901+167%1.664+881%-151.815+1030%-53.827+430%
Quick Ratio--19.84620.484-3%14.077+41%14.909+33%17.887+11%
Return On Assets---0.128-0.116-9%-0.135+6%-0.070-45%-0.093-27%
Return On Equity---0.163-0.132-19%-0.154-5%-0.270+65%-0.169+4%
Total Gains Per Share---0.2770.068-505%0.025-1223%0.089-410%0.054-615%
Total Gains Per Share Growth--0.203-1.415+797%0.291-30%-2.922+1538%-1.557+866%
Usd Book Value--259526000.000311538500.000-17%181202500.000+43%158181100.000+64%107958601.975+140%
Usd Book Value Change Per Share---0.2770.068-505%0.025-1223%0.089-410%0.054-615%
Usd Book Value Per Share--2.1502.581-17%1.501+43%1.310+64%0.894+140%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.351-0.330-6%-0.221-37%-0.137-61%-0.141-60%
Usd Price Per Share23.060+22%17.94015.278+17%8.910+101%6.775+165%18.257-2%
Usd Profit---42351000.000-39795750.000-6%-26730250.000-37%-16526650.000-61%-16452803.900-61%
Usd Revenue----0%-0%-0%8841250.000-100%
Usd Total Gains Per Share---0.2770.068-505%0.025-1223%0.089-410%0.054-615%
 EOD+2 -3MRQTTM+6 -21YOY+10 -175Y+13 -1410Y+14 -15

4.2. Fundamental Score

Let's check the fundamental score of IVERIC bio Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-65.733
Price to Book Ratio (EOD)Between0-110.727
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than119.846
Current Ratio (MRQ)Greater than113.400
Debt to Asset Ratio (MRQ)Less than10.218
Debt to Equity Ratio (MRQ)Less than10.278
Return on Equity (MRQ)Greater than0.15-0.163
Return on Assets (MRQ)Greater than0.05-0.128
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of IVERIC bio Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5060.288
Ma 20Greater thanMa 5020.661
Ma 50Greater thanMa 10020.589
Ma 100Greater thanMa 20016.846
OpenGreater thanClose22.500
Total4/5 (80.0%)



Latest Balance Sheet

Balance Sheet of 2022-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets331,790
Total Liabilities72,264
Total Stockholder Equity259,526
 As reported
Total Liabilities 72,264
Total Stockholder Equity+ 259,526
Total Assets = 331,790

Assets

Total Assets331,790
Total Current Assets329,478
Long-term Assets329,478
Total Current Assets
Cash And Cash Equivalents 153,100
Short-term Investments 167,435
Other Current Assets 8,943
Total Current Assets  (as reported)329,478
Total Current Assets  (calculated)329,478
+/-0
Long-term Assets
Property Plant Equipment 2,312
Long-term Assets  (as reported)2,312
Long-term Assets  (calculated)2,312
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities24,588
Long-term Liabilities47,676
Total Stockholder Equity259,526
Total Current Liabilities
Short-term Debt 1,604
Accounts payable 11,601
Other Current Liabilities 11,383
Total Current Liabilities  (as reported)24,588
Total Current Liabilities  (calculated)24,588
+/-0
Long-term Liabilities
Long term Debt 47,649
Capital Lease Obligations Min Short Term Debt27
Long-term Liabilities  (as reported)47,676
Long-term Liabilities  (calculated)47,676
+/-0
Total Stockholder Equity
Common Stock121
Retained Earnings -805,745
Accumulated Other Comprehensive Income -395
Capital Surplus 1,065,545
Total Stockholder Equity (as reported)259,526
Total Stockholder Equity (calculated)259,526
+/-0
Other
Capital Stock121
Cash and Short Term Investments 320,535
Common Stock Shares Outstanding 120,277
Common Stock Total Equity121
Liabilities and Stockholders Equity 331,790
Net Debt -151,469
Net Invested Capital 307,175
Net Tangible Assets 259,526
Net Working Capital 304,890
Short Long Term Debt Total 1,631



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-30
> Total Assets 
0
4,879
0
73,483
238,376
217,682
297,093
478,126
490,486
498,370
517,425
471,049
450,751
428,851
398,845
385,854
350,585
299,630
238,272
201,788
182,982
175,576
161,551
151,661
140,957
137,165
124,096
113,608
98,823
130,187
115,714
249,950
234,595
216,754
187,402
165,667
247,790
389,358
352,705
319,756
331,790
331,790319,756352,705389,358247,790165,667187,402216,754234,595249,950115,714130,18798,823113,608124,096137,165140,957151,661161,551175,576182,982201,788238,272299,630350,585385,854398,845428,851450,751471,049517,425498,370490,486478,126297,093217,682238,37673,48304,8790
   > Total Current Assets 
0
4,837
0
73,451
238,333
217,400
268,332
442,155
462,644
473,625
492,904
460,278
288,083
306,485
331,784
355,088
346,941
295,887
235,796
199,854
181,653
171,505
157,747
147,910
137,263
133,287
119,034
110,591
96,973
128,624
115,241
249,697
234,399
216,603
187,276
163,688
246,040
387,488
350,967
317,222
329,478
329,478317,222350,967387,488246,040163,688187,276216,603234,399249,697115,241128,62496,973110,591119,034133,287137,263147,910157,747171,505181,653199,854235,796295,887346,941355,088331,784306,485288,083460,278492,904473,625462,644442,155268,332217,400238,33373,45104,8370
       Cash And Cash Equivalents 
0
4,305
0
73,187
236,079
210,596
66,562
248,498
94,804
39,814
39,568
36,720
254,895
221,861
183,822
194,054
165,604
133,930
92,554
140,917
180,217
166,972
154,911
145,991
135,208
131,201
116,639
106,889
94,851
125,699
108,352
245,735
122,819
66,373
29,335
50,363
179,879
261,447
191,867
141,113
153,100
153,100141,113191,867261,447179,87950,36329,33566,373122,819245,735108,352125,69994,851106,889116,639131,201135,208145,991154,911166,972180,217140,91792,554133,930165,604194,054183,822221,861254,89536,72039,56839,81494,804248,49866,562210,596236,07973,18704,3050
       Short-term Investments 
0
0
0
0
0
0
196,500
188,733
313,978
423,746
393,718
412,320
26,147
74,731
109,104
104,658
155,552
155,348
135,061
55,525
0
0
0
0
0
0
0
0
0
0
0
0
108,303
143,674
150,866
109,519
62,091
120,302
153,796
170,850
167,435
167,435170,850153,796120,30262,091109,519150,866143,674108,30300000000000055,525135,061155,348155,552104,658109,10474,73126,147412,320393,718423,746313,978188,733196,500000000
       Net Receivables 
0
0
0
0
0
0
0
837
50,000
960
50,249
247
1,500
4,389
36,559
54,480
24,271
3,531
3,531
674
0
1,387
1,387
0
0
0
0
1,765
1,012
882
4,706
1,764
1,764
1,765
1,765
0
0
0
0
0
0
0000001,7651,7651,7641,7644,7068821,0121,76500001,3871,38706743,5313,53124,27154,48036,5594,3891,50024750,24996050,0008370000000
       Other Current Assets 
0
533
0
264
2,254
6,804
5,270
4,924
3,862
9,105
9,369
10,991
7,041
5,504
2,299
1,896
1,514
3,078
4,650
2,738
1,436
3,146
2,836
1,919
2,055
2,086
2,395
1,937
1,110
2,043
2,183
2,198
1,513
4,791
5,310
3,806
4,070
5,739
5,304
5,259
8,943
8,9435,2595,3045,7394,0703,8065,3104,7911,5132,1982,1832,0431,1101,9372,3952,0862,0551,9192,8363,1461,4362,7384,6503,0781,5141,8962,2995,5047,04110,9919,3699,1053,8624,9245,2706,8042,25426405330
   > Long-term Assets 
0
42
0
32
43
282
28,761
35,971
27,842
24,745
24,521
10,771
162,668
122,366
67,061
30,766
3,644
3,743
2,476
1,934
1,329
4,071
3,804
3,751
3,694
3,878
5,062
3,017
1,850
1,563
473
253
196
151
126
1,979
1,750
1,870
1,738
2,534
2,312
2,3122,5341,7381,8701,7501,9791261511962534731,5631,8503,0175,0623,8783,6943,7513,8044,0711,3291,9342,4763,7433,64430,76667,061122,366162,66810,77124,52124,74527,84235,97128,76128243320420
       Property Plant Equipment 
0
42
0
32
32
27
743
826
1,289
1,555
1,563
1,809
2,590
3,466
3,350
3,263
3,174
3,281
2,473
1,888
1,302
518
468
424
379
335
1,522
1,241
957
669
461
241
196
146
124
1,979
1,750
1,870
1,738
2,534
2,312
2,3122,5341,7381,8701,7501,9791241461962414616699571,2411,5223353794244685181,3021,8882,4733,2813,1743,2633,3503,4662,5901,8091,5631,5551,2898267432732320420
       Long Term Investments 
0
0
0
0
0
0
27,763
15,255
0
0
0
0
144,944
0
63,211
27,011
0
0
0
0
0
0
0
0
0
3,529
3,529
1,765
882
882
0
0
0
0
0
0
0
0
0
0
0
000000000008828821,7653,5293,52900000000027,01163,2110144,944000015,25527,763000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,327
3,315
3,543
11
1,776
893
894
12
12
0
125
2
0
0
0
0
0
0
0000002125012128948931,776113,5433,3153,32700000000000000000000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
19,635
26,187
4,467
4,412
8,443
14,632
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000014,6328,4434,4124,46726,18719,6350000000
> Total Liabilities 
0
14,410
0
46,221
49,575
47,962
89,888
318,695
314,591
351,249
355,832
357,273
367,640
368,904
365,622
371,349
387,174
394,248
369,927
350,608
139,107
137,535
133,474
134,131
135,530
13,206
10,127
11,875
9,361
12,984
11,084
11,909
20,009
25,191
20,214
26,094
21,304
28,830
19,551
26,810
72,264
72,26426,81019,55128,83021,30426,09420,21425,19120,00911,90911,08412,9849,36111,87510,12713,206135,530134,131133,474137,535139,107350,608369,927394,248387,174371,349365,622368,904367,640357,273355,832351,249314,591318,69589,88847,96249,57546,221014,4100
   > Total Current Liabilities 
0
14,410
0
4,554
7,908
6,295
6,555
35,362
24,039
19,831
19,523
22,680
34,644
37,505
34,226
39,696
57,182
65,918
43,258
25,601
14,107
12,535
8,474
9,131
10,530
13,206
9,882
11,875
9,361
12,984
10,978
11,818
19,933
25,130
20,163
24,992
20,443
28,211
19,166
26,479
24,588
24,58826,47919,16628,21120,44324,99220,16325,13019,93311,81810,97812,9849,36111,8759,88213,20610,5309,1318,47412,53514,10725,60143,25865,91857,18239,69634,22637,50534,64422,68019,52319,83124,03935,3626,5556,2957,9084,554014,4100
       Short-term Debt 
0
11,040
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
985
989
745
495
219
53
54
54
55
937
945
952
955
1,724
1,604
1,6041,7249559529459375554545321949574598998500000000000000000000000011,0400
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
985
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000098500000000000000000000000000
       Accounts payable 
0
866
0
1,987
4,431
3,810
3,753
4,039
6,706
8,707
4,783
6,150
7,850
12,018
7,287
7,769
10,389
12,032
8,657
6,268
7,895
7,551
3,278
3,994
4,614
5,869
2,987
3,241
3,666
5,629
2,375
4,634
7,012
12,792
6,976
8,643
8,130
12,856
5,294
8,178
11,601
11,6018,1785,29412,8568,1308,6436,97612,7927,0124,6342,3755,6293,6663,2412,9875,8694,6143,9943,2787,5517,8956,2688,65712,03210,3897,7697,28712,0187,8506,1504,7838,7076,7064,0393,7533,8104,4311,98708660
       Other Current Liabilities 
0
2,505
0
2,567
3,477
2,485
2,802
31,323
14,127
7,918
8,103
9,775
20,080
18,820
21,727
25,151
40,017
47,240
27,955
12,687
6,212
4,984
5,196
5,137
5,916
7,337
5,910
7,645
4,950
6,860
8,384
7,131
12,867
12,284
13,132
15,412
11,368
14,403
12,917
16,577
11,383
11,38316,57712,91714,40311,36815,41213,13212,28412,8677,1318,3846,8604,9507,6455,9107,3375,9165,1375,1964,9846,21212,68727,95547,24040,01725,15121,72718,82020,0809,7758,1037,91814,12731,3232,8022,4853,4772,56702,5050
   > Long-term Liabilities 
0
0
0
41,667
41,667
41,667
83,333
283,333
290,552
331,418
336,309
334,593
332,996
331,399
331,396
331,653
329,992
328,330
326,669
325,007
125,000
125,000
125,000
125,000
125,000
0
245
0
0
0
106
91
76
61
51
1,102
861
619
385
331
47,676
47,6763313856198611,102516176911060002450125,000125,000125,000125,000125,000325,007326,669328,330329,992331,653331,396331,399332,996334,593336,309331,418290,552283,33383,33341,66741,66741,667000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
19,635
26,187
4,467
4,412
8,443
14,632
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000014,6328,4434,4124,46726,18719,6350000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
200,000
207,219
206,418
211,309
209,593
207,996
0
206,396
206,653
0
203,330
201,669
200,007
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000200,007201,669203,3300206,653206,3960207,996209,593211,309206,418207,219200,0000000000
> Total Stockholder Equity
0
-9,531
0
27,263
188,801
169,720
207,205
159,431
175,895
147,121
161,593
113,776
83,111
59,947
33,223
14,505
-36,589
-94,618
-131,655
-148,820
43,875
38,041
28,077
17,530
5,427
123,959
113,969
101,733
89,462
117,203
104,630
238,041
214,586
191,563
167,188
139,573
226,486
360,528
333,154
292,946
259,526
259,526292,946333,154360,528226,486139,573167,188191,563214,586238,041104,630117,20389,462101,733113,969123,9595,42717,53028,07738,04143,875-148,820-131,655-94,618-36,58914,50533,22359,94783,111113,776161,593147,121175,895159,431207,205169,720188,80127,2630-9,5310
   Common Stock
0
1
0
23
31
31
33
33
34
34
34
35
35
35
35
36
36
36
36
36
36
36
36
36
36
41
41
41
42
50
50
89
90
90
90
90
104
115
116
117
121
121117116115104909090908950504241414136363636363636363636353535353434343333313123010
   Retained Earnings Total Equity-805,745-763,394-714,131-679,595-646,562-622,011-591,868-565,073-539,641-514,191-495,602-480,526-463,048-448,611-434,168-421,667-525,781-511,036-497,827-484,754-475,212-664,285-642,081-598,9590-471,785-441,8400-369,890-330,317-293,186-299,822-245,367-256,231-203,732-183,050-162,6610000
   Accumulated Other Comprehensive Income 
0
-154
0
0
0
-175
-187
25
35
-65
-17
24
79
-473
4
-118
-159
-212
-222
-186
-3,430
-827
-877
-921
-966
-422,000
0
0
0
-807
0
0
1
3
2
3
-11
-90
-394
-528
-395
-395-528-394-90-11323100-807000-422,000-966-921-877-827-3,430-186-222-212-159-1184-4737924-17-653525-187-175000-1540
   Capital Surplus 
0
0
0
0
351,431
352,739
410,886
415,604
421,193
428,390
435,204
444,034
452,887
0
475,024
486,372
0
504,517
510,612
515,615
519,051
522,759
525,868
528,530
531,172
545,585
548,096
550,303
552,468
597,679
600,182
752,143
754,136
756,543
758,964
761,491
872,955
1,040,098
1,047,563
1,056,751
1,065,545
1,065,5451,056,7511,047,5631,040,098872,955761,491758,964756,543754,136752,143600,182597,679552,468550,303548,096545,585531,172528,530525,868522,759519,051515,615510,612504,5170486,372475,0240452,887444,034435,204428,390421,193415,604410,886352,739351,4310000
   Treasury Stock00000000000000000000000000000000000000000
   Other Stockholders Equity 
0
154
0
174,980
351,431
352,914
411,073
415,604
421,193
428,390
435,204
444,034
452,887
465,924
475,024
486,372
496,210
504,517
510,612
515,615
519,051
523,586
526,745
529,451
532,138
967,585
548,096
550,303
552,468
598,486
600,182
752,143
754,136
756,543
758,964
761,491
872,955
1,040,098
1,047,563
1,056,751
1,065,545
1,065,5451,056,7511,047,5631,040,098872,955761,491758,964756,543754,136752,143600,182598,486552,468550,303548,096967,585532,138529,451526,745523,586519,051515,615510,612504,517496,210486,372475,024465,924452,887444,034435,204428,390421,193415,604411,073352,914351,431174,98001540



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue--
Gross Profit-0
 
Operating Income (+$)
Gross Profit-
Operating Expense-114,757
Operating Income-114,757-114,757
 
Operating Expense (+$)
Research Development85,068
Selling General Administrative29,689
Selling And Marketing Expenses-
Operating Expense114,757114,757
 
Net Interest Income (+$)
Interest Income245
Interest Expense-0
Net Interest Income245245
 
Pretax Income (+$)
Operating Income-114,757
Net Interest Income245
Other Non-Operating Income Expenses-10
Income Before Tax (EBT)-114,522-114,992
EBIT - interestExpense = -114,757
-114,522
-114,522
Interest Expense0
Earnings Before Interest and Taxes (ebit)-114,757-114,522
Earnings Before Interest and Taxes (ebitda)-114,718
 
After tax Income (+$)
Income Before Tax-114,522
Tax Provision-0
Net Income From Continuing Ops-114,522-114,522
Net Income-114,522
Net Income Applicable To Common Shares-114,522
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses114,757
Total Other Income/Expenses Net235-235
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
ZCL.CC
8 hours ago

I found you a Golden Cross on the daily chart of ZCL.CC.

ZCL.CC Daily Candlestick Chart
XPC.CC
8 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of XPC.CC.

XPC.CC Daily Candlestick Chart
XNC.CC
8 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of XNC.CC.

XNC.CC Daily Candlestick Chart
XMY.CC
8 hours ago

I found you a Three White Soldiers Candle Pattern on the daily chart of XMY.CC.

XMY.CC Daily Candlestick Chart
XFT.CC
8 hours ago

I found you a Rising Three Methods Candle Pattern on the daily chart of XFT.CC.

XFT.CC Daily Candlestick Chart
WING.CC
8 hours ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of WING.CC.

WING.CC Daily Candlestick Chart
vUSDC.CC
8 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of vUSDC.CC.

vUSDC.CC Daily Candlestick Chart
VOLLAR.CC
8 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of VOLLAR.CC.

VOLLAR.CC Daily Candlestick Chart
UUU.CC
8 hours ago

I found you a MACD Bearish Reversal Divergence on the daily chart of UUU.CC.

UUU.CC Daily Candlestick Chart
UGAS.CC
8 hours ago

I found you a Bearish Three Line Strike Candle Pattern on the daily chart of UGAS.CC.

UGAS.CC Daily Candlestick Chart
UBQ.CC
8 hours ago

I found you a Death Cross on the daily chart of UBQ.CC.

UBQ.CC Daily Candlestick Chart
TRXBULL.CC
8 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of TRXBULL.CC.

TRXBULL.CC Daily Candlestick Chart
TH.CC
8 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of TH.CC.

TH.CC Daily Candlestick Chart
THC.CC
8 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of THC.CC.

THC.CC Daily Candlestick Chart
TEL.CC
8 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of TEL.CC.

TEL.CC Daily Candlestick Chart
SWG.CC
9 hours ago

I found you a Death Cross on the daily chart of SWG.CC.

SWG.CC Daily Candlestick Chart
SNC.CC
9 hours ago

I found you a Death Cross on the daily chart of SNC.CC.

SNC.CC Daily Candlestick Chart
SHROOM.CC
9 hours ago

I found you a Morning Star Candle Pattern on the daily chart of SHROOM.CC.

SHROOM.CC Daily Candlestick Chart
SATT.CC
9 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of SATT.CC.

SATT.CC Daily Candlestick Chart
RYO.CC
9 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of RYO.CC.

RYO.CC Daily Candlestick Chart
REAP.CC
9 hours ago

I found you a Bearish Three Line Strike Candle Pattern on the daily chart of REAP.CC.

REAP.CC Daily Candlestick Chart
RBN.CC
9 hours ago

I found you a Death Cross on the daily chart of RBN.CC.

RBN.CC Daily Candlestick Chart
RAK.CC
9 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of RAK.CC.

RAK.CC Daily Candlestick Chart
PLAY.CC
9 hours ago

I found you a Death Cross on the daily chart of PLAY.CC.

PLAY.CC Daily Candlestick Chart